Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on June 25, 2026. The filing serves to distribute a press release dated June 25, 2026, as Exhibit 99.1. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet referencing a press release and does not contain embedded financial tables or statements.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. Specific operational or financial changes are detailed in the referenced press release (Exhibit 99.1), which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is signed by André Choulika, Chief Executive Officer, but contains no narrative commentary.
Key Facts for Investor Verification
- Verify the content of the press release dated June 25, 2026 (Exhibit 99.1), as the cover sheet contains no substantive data.
- Confirm the company's current cash position and runway, as no financial figures are present in this filing.
- Review the full text of the press release for any updates on clinical trials, partnerships, or regulatory milestones.